// OVERVIEW
Global biopharmaceutical company mentioned in the context of hepatitis C drug market competition.
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
mention·The a16z Show·APRIL 29, 2026
“It was either Amgen or Gilead did it first... then the actual price on the drug that is paid by the insurers, the net price, came down immediately. Because when you have like 10 drugs in a space, the cost of the drug is like 90% down.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.